Translatum Medicus Inc is a preclinical drug development company focused on macrophage modulation to treat blinding eye disease, with a patented lead drug candidate, TMi-018 for the treatment of dry Age-Related Macular Degeneration (AMD). 

Translatum is based in the Johnson & Johnson Innovation Incubator JLABS@Toronto, and has been increasingly gaining traction as one of the most innovative early stage ophthalmic biotech companies.  

Biotechnology

Health Care

Therapeutics

Translatum Medicus Inc

Translatum Medicus Inc's headquarters in Toronto, Canada

Description

People (1)

Kenneth Howling

Jobs